Page last updated: 2024-08-22

cladribine and Hepatitis B Virus Infection

cladribine has been researched along with Hepatitis B Virus Infection in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cola, G; Di Mauro, G; Grimaldi, A; Landi, D; Marfia, GA; Mataluni, G; Nicoletti, CG1
Annovazzi, P; Brescia Morra, V; Buonomo, AR; Buscarinu, MC; Calabrese, M; Cavalla, P; Cocco, E; Cordioli, C; De Angelis, M; De Luca, G; Di Filippo, M; Ferraro, D; Gajofatto, A; Gasperini, C; Gentile, I; Lanzillo, R; Maniscalco, GT; Moccia, M; Nociti, V; Paolicelli, D; Petruzzo, M; Pinardi, F; Radaelli, M; Scotto, R; Solaro, C; Spiezia, AL; Tomassini, V; Viceconte, G; Zappulo, E1
Busuttil, DP; Chasty, RC; Copplestone, JA; Fraser, M; Prentice, AG1

Other Studies

3 other study(ies) available for cladribine and Hepatitis B Virus Infection

ArticleYear
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus.
    Multiple sclerosis and related disorders, 2022, Volume: 57

    Topics: Cladribine; COVID-19; Hepatitis B; Hepatitis B virus; Humans; Multiple Sclerosis; SARS-CoV-2

2022
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
    Journal of neurology, 2022, Volume: 269, Issue:6

    Topics: Antiviral Agents; Cladribine; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Middle Aged; Multiple Sclerosis; Retrospective Studies; Rituximab; Virus Activation

2022
Delayed reactivation of hepatitis B infection after cladribine.
    Lancet (London, England), 1996, Jul-13, Volume: 348, Issue:9020

    Topics: Aged; Cladribine; Hepatitis B; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Recurrence

1996